Enterprising Investor
9 years ago
The Chemours Company Reports Third Quarter 2016 Results; Significant Earnings and Margins Increases Driven by Progress on Transformation Plan and Improved Market Conditions (11/06/16)
WILMINGTON, Del., Nov. 6, 2016 /PRNewswire/ --
Third Quarter 2016 Highlights
•Net Sales of $1.4 billion
•Net Income of $204 million, or $1.11 per diluted share, including
gain on asset sales of $169 million, impairment charges of $46 million, interest expense of $51 million and restructuring costs of $14 million
•Adjusted EBITDA of $268 million
•Adjusted Net Income of $112 million, or $0.61 per diluted share
Other Highlights
•Continued progress on all transformation plan objectives, including cost reductions, growth initiatives and portfolio rationalization
•Improved cash from operating activities by ~$440 million year-to-date
•Retired $315 million of long term debt through October 31, 2016
•Generated ~$685 million in gross proceeds from Chemical Solutions divestitures
•Increased full-year Adjusted EBITDA outlook to be between $740 and $775 million based on a net income range of approximately $265 to $290 million
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced financial results for the third quarter 2016.
Chemours President and CEO Mark Vergnano said, "We continue to make excellent progress on all aspects of our transformation plan, realizing an incremental $60 million of cost savings during the quarter. We are benefiting from the OpteonTM refrigerant ramp up and the expansion of our low-cost TiO2 capacity at Altamira, while at the same time, delivering our planned cost reductions." He continued, "We successfully completed the Chemical Solutions portfolio review during the quarter, generating substantial proceeds. And, in the quarter, our Titanium Technologies business benefited from more favorable market conditions, while the fluoropolymers market remained challenged. Transformation initiatives are pervasive throughout the company and our results speak for themselves."
Third quarter net sales were $1.4 billion, a decrease of 6 percent from $1.5 billion in the prior-year quarter, primarily due to the impact of divestitures. Third quarter net income was $204 million, or $1.11 per diluted share, versus net loss of $29 million, or ($0.16) per diluted share in the prior-year quarter. Adjusted EBITDA for the third quarter was $268 million versus $169 million in the prior-year quarter. Benefits from cost reductions, improved average prices in Titanium Technologies and improved profitability in Fluoroproducts was partially offset by the loss of Adjusted EBITDA from the asset sales within Chemical Solutions.
Sequentially, sales increased 1 percent to $1.4 billion in the third quarter. Third quarter net income was $222 million higher, or $1.21 per diluted share, versus the second quarter net loss of $18 million or ($0.10) per diluted share. The sales improvement was largely driven by higher seasonal volumes in Titanium Technologies and Fluoroproducts supplemented by higher TiO2 pricing. Third quarter Adjusted EBITDA increased $81 million from $187 million in the second quarter of 2016. Improved pricing in Titanium Technologies and OpteonTM refrigerant growth in Fluoroproducts were the primary drivers of the improved sequential performance, which were partially offset by unfavorable Corporate and Other expenses.
Titanium Technologies
In the third quarter, Titanium Technologies segment sales were $625 million, a 1 percent increase versus the prior-year quarter. Improved year-over-year global average TiO2 pricing increased sales 2 percent which was partially offset by minimal currency headwinds. Year-over-year, TiO2 volume was higher in all regions outside of China. Segment Adjusted EBITDA was $144 million, an 80 percent increase over the prior-year quarter. The increase in Adjusted EBITDA was primarily due to the benefits of price increases, transformation plan cost savings, and operational efficiencies.
Sequentially, versus the second quarter of 2016, sales increased 5 percent and Adjusted EBITDA increased $33 million, or 30 percent. The increase in sales was due to slightly stronger volumes and a higher global average price increase of approximately 3 percent. A volume increase of 2 percent was the result of stronger demand primarily in Asia and Latin America. Higher Adjusted EBITDA was driven by the benefits of global average price increases, stronger volumes and better utilization resulting in lower costs.
Fluoroproducts
Fluoroproducts segment sales in the third quarter were $591 million, an increase of 3 percent versus the prior-year quarter. A substantial increase in demand for Opteon™ refrigerants was mostly offset by government-imposed volume reductions of base refrigerants as well as competitive pricing pressure within fluoropolymers. Segment Adjusted EBITDA was $143 million, a 57 percent improvement versus the prior-year quarter. Increased contributions from Opteon™ refrigerants and transformation cost reductions were partially offset by unfavorable pricing and mix within our fluoropolymers product lines.
Sequentially, versus the second quarter of 2016, sales and Adjusted EBITDA increased 3 percent and 36 percent, respectively. The Opteon™ refrigerants ramp up and strong demand for certain fluoropolymers products more than offset regulatory-driven lower demand in base refrigerant sales. In addition to Opteon™ refrigerant growth, the increase in Adjusted EBITDA was primarily attributed to cost reductions.
Chemical Solutions
In the third quarter, Chemical Solutions segment sales were $182 million, a 38 percent decline versus the prior-year quarter. Lower sales were driven by the divestitures of the Clean and Disinfect business, Sulfur Products and Beaumont Aniline facility, as well as reduced average prices based on contractual pass-through terms. Segment Adjusted EBITDA was $9 million, $1 million above the prior-year quarter, reflecting lower operating costs partially offset by the impacts of the divestitures.
Sequentially, sales decreased 15 percent versus the second quarter of 2016, while Adjusted EBITDA was $2 million lower driven primarily by portfolio changes completed in the current quarter.
In the third quarter, we completed the sales of Sulfur Products and the Clean and Disinfect business to Veolia and LANXESS, respectively, for combined proceeds of approximately $544 million. Also, consistent with the company's plan to streamline the portfolio and deliver cost savings in 2017, the company ceased production at the Niagara Reactive Metals facility at the end of September.
Corporate and Other
Corporate and Other represented a negative $28 million of Adjusted EBITDA, an increase of $18 million versus the prior-year quarter. Higher expenses were primarily related to performance-related compensation adjustments and other miscellaneous expenses in the quarter. Versus the second quarter of 2016, Corporate and Other expenses declined $12 million largely due to timing of expenses.
The company realized a cash tax rate of approximately 16 percent in the quarter. For the full year 2016, the company expects its cash tax rate to be in the low-twenties on a percentage basis, taking into consideration the company's anticipated geographic mix of earnings and implications of all divestitures during the year.
Liquidity
As of September 30, 2016, gross consolidated debt was $3.8 billion. Debt, net of cash, was $2.8 billion. In the quarter, the company retired approximately $115 million of its bonds. Cash balances were $957 million at September 30, 2016. In October 2016, the company retired an additional $107 million of its bonds, resulting in over $315 million of total long term debt retired year-to-date. As a result, the company expects to save approximately $19 million annually from lower interest obligations.
Improved inventory management along with the start of seasonal working capital unwind drove strong progress in working capital results and led to free cash flow of $132 million, up $124 million versus the previous-year quarter. Year-to-date working capital1 performance and free cash flow improved by $448 million and $601 million, respectively, versus the prior-year.
Outlook
"We remain disciplined and focused on executing our Five-Point Transformation Plan," Vergnano commented. "We expect the transformation plan improvements, along with a stronger price environment for TiO2 and increased OpteonTM refrigerants adoption to continue to enhance earnings, despite loss of earnings from divestitures, base refrigerant sales timing and unfavorable Fluoropolymers mix. We now expect full-year 2016 Adjusted EBITDA to be between $740 million and $775 million. We are pleased with the progress we have made year-to-date, and believe we are in a stronger position as we move forward."
Conference Call
As previously announced, Chemours will hold a conference call and webcast on Monday, November 7, 2016 at 8:30 AM EST. The webcast and additional presentation materials can be accessed by visiting the Events & Presentations page of Chemours' investor website, investors.chemours.com. A webcast replay of the conference call will be available on the Chemours' investor website.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 8,000 employees across 25 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com.
[tables deleted]
http://www.prnewswire.com/news-releases/the-chemours-company-reports-third-quarter-2016-results-significant-earnings-and-margins-increases-driven-by-progress-on-transformation-plan-and-improved-market-conditions-300358103.html
Enterprising Investor
9 years ago
The Chemours Company Announces Second Quarter Results; Reports Substantial Progress on Transformation Plan Initiatives (8/08/16)
WILMINGTON, Del., Aug. 8, 2016 /PRNewswire/ --
Second Quarter 2016 Highlights
•Net Sales of $1.4 billion
•Net Loss of $18 million, or ($0.10) per diluted share, including impairment charges of $63 million, interest expense of $50 million and restructuring costs of $9 million
•Adjusted EBITDA of $187 million
•Adjusted Net Income of $49 million, or $0.27 per diluted share
Other Year-To-Date Highlights
•Continued progress on Five-Point Transformation Plan objectives, including delivery of ~$100 million of cost reductions in the first half of 2016, completion of the strategic review of Chemical Solutions portfolio, commercial startup of Altamira TiO2 capacity expansion and announced investment in additional Opteon™ capacity
•$359 million improvement in cash flow from operating activities in the first half
•Reduced ~$100 million of long term debt year-to-date
•Completed the sale of the Sulfur business to Veolia for approximately $325 million
Today, The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced financial results for the second quarter 2016.
Chemours President and CEO Mark Vergnano said, "Our second quarter results reflect our focused execution against our Five-Point Transformation Plan and our drive to deliver on our commitments to all our stakeholders. We have just celebrated our first anniversary as a public company, and we are pleased with the progress we have made in that time to strengthen our business model, reduce costs, and optimize our company portfolio. At this point, we have completed the strategic review of our Chemical Solutions portfolio, closed the sale of our Sulfur business for approximately $325 million and announced the sale of our Clean and Disinfect business for $230 million. We began commercial production at our new TiO2 plant in Altamira, Mexico and have been encouraged by improvement in the titanium technologies segment with increasing TiO2 prices. Overall, I am very pleased that we have delivered approximately $100 million in cost reductions, improved margins, improved our working capital, streamlined our portfolio and modestly improved our balance sheet in the first half of 2016."
Second quarter net sales were $1.4 billion, a decrease of 8 percent from $1.5 billion in the prior-year quarter. Second quarter net loss was $18 million, or ($0.10) per diluted share, versus net loss of $18 million, or ($0.10) per diluted share on a pro forma basis in the prior-year quarter. Adjusted EBITDA for the second quarter was $187 million versus $127 million in the prior-year quarter. Improved profitability in Fluoroproducts and cost reductions throughout the company were partially offset by lower average prices in Titanium Technologies and Chemical Solutions along with approximately $9 million of unfavorable currency movements versus the prior-year quarter.
Sequentially, sales increased by $86 million, an increase of 7 percent from $1.3 billion in the first quarter. Second quarter net loss was $18 million, or ($0.10) per diluted share down from net income of $51 million or $0.28 per diluted share. The net loss was primarily driven by asset impairment charges of $63 million in the second quarter. Second quarter Adjusted EBITDA increased by $59 million versus $128 million in the first quarter of 2016. The improved performance was primarily driven by higher seasonal volumes in Titanium Technologies and Fluoroproducts and supplemented by higher TiO2 pricing and lower costs. These were partially offset by unfavorable Corporate and Other expenses.
Titanium Technologies
In the second quarter, Titanium Technologies segment sales were $596 million, a 7 percent decline versus the prior-year quarter. Lower year-over-year pricing reduced net sales 6 percent and lower volume of non-TiO2 product lines and the timing of TiO2 shipments reduced net sales 1 percent. Strong demand in North America and EMEA was offset by weaker volumes in Asia and Latin America versus the prior-year quarter. Segment Adjusted EBITDA was $111 million, a 22 percent improvement compared to the prior-year quarter. Benefits from cost reductions and operational efficiencies drove the improvement in Adjusted EBITDA, but were partially offset by the lower average prices. Currency movements contributed a moderate benefit in the quarter versus the previous-year quarter.
Sequentially, versus the first quarter of 2016, sales increased 14 percent and Adjusted EBITDA increased $57 million, or 105 percent. The increase in sales was due to seasonally stronger volumes and higher global average price increase of approximately 5 percent. Volume increased 10 percent driven by sequentially higher demand in all regions except Latin America. The benefits of global average price increases, stronger volumes, transformation plan cost savings and a $4 million impact from favorable currency movements drove the increase in Adjusted EBITDA. In August 2016, Chemours communicated to customers in EMEA and Latin America that an additional $150 per tonne price increase will be effective September 1, 2016.
Fluoroproducts
Fluoroproducts segment sales in the second quarter were $573 million, a decrease of 3 percent versus the prior-year quarter. Stronger demand for Opteon™ refrigerants in both Europe and the U.S. delivered a significant increase in volume that was offset by regulated volume reductions of base refrigerants, weaker demand for fluoropolymer products into consumer electronics markets and lower pricing due to product mix. Segment Adjusted EBITDA was $105 million, a 94 percent increase versus the prior-year quarter. Transformation plan cost reductions, improved manufacturing operations and increased Opteon™ refrigerant contributions were partially offset by unfavorable mix of fluoropolymers products and approximately $11 million of unfavorable currency movements versus the prior-year quarter.
Sequentially, versus the first quarter of 2016, sales and Adjusted EBITDA increased 8 percent and 24 percent, respectively. Seasonally stronger refrigerant sales, along with continued ramp up in Opteon™ refrigerant volumes, more than offset weaker prices related to unfavorable mix of fluoropolymer sales. The increase in Adjusted EBITDA was driven by Opteon™ refrigerant growth, lower costs and approximately $4 million of benefit from currency movements in the quarter that were partially offset by the unfavorable product mix.
Chemical Solutions
In the second quarter, Chemical Solutions segment sales were $214 million, a 23 percent decline versus the prior-year quarter, primarily due to pass-through impact on prices of lower raw material costs and the portfolio impact of the Beaumont, TX aniline facility sale. Segment Adjusted EBITDA was $11 million, $7 million above the prior-year quarter, reflecting continued benefits from transformation plan initiatives that are lowering operating costs across the segment. The timing of the planned cyanide expansion has been pushed back due to permitting delays, and Chemours now expects the majority of capital expenditures related to the construction will take place in 2017.
Sequentially, sales decreased 13 percent versus the first quarter of 2016 primarily as a result of pass-through pricing, while Adjusted EBITDA was $1 million higher driven primarily by lower operating costs in the second quarter.
In the second quarter, the company completed its strategic review of the Chemicals Solutions segment. On July 29, 2016, the company completed the sale of its Sulfur business to Veolia for approximately $325 million. Chemours expects to close the sale of the Clean and Disinfect (C&D) business to LANXESS for $230 million in the second half of 2016. During the second quarter, activities to shut down the Reactive Metals business in Niagara, NY continued with expected closure by the end of this year.
Corporate and Other
Corporate and Other represented a negative $40 million of Adjusted EBITDA. Corporate and Other expenses in the second quarter of 2016 increased $18 million and $19 million versus the prior-year quarter and the first quarter 2016, respectively. The increase in expenses primarily related to performance-related compensation adjustments, litigation and other miscellaneous expenses in the quarter.
The company recognized a cash tax rate of approximately 25 percent in the quarter, excluding restructuring and other nonrecurring charges. For the full year 2016, the company expects its cash tax rate to be in the high-teens percentages, taking into consideration the company's anticipated geographic mix of earnings and additional implications anticipated with the Sulfur and C&D transactions.
Liquidity
As of June 30, 2016, gross consolidated debt was $3.9 billion. Debt, net of cash, was $3.5 billion.
Cash balances were $383 million at June 30, 2016. In the quarter, the company retired $50 million of Term Loan B and $42 million of its bonds for a combined cash amount of $85 million. An additional $8 million of bonds were retired in July 2016, completing $100 million of total long term debt repurchased year-to-date. As a result of these purchases, the company expects to save approximately $5 million annually from lower interest obligations.
Excluding the impact of interest payments in the quarter, the company continued to improve working capital performance through better inventory management and collections and payables processes. Year-to-date working capital1 performance and free cash flow improved by $219 million and $347 million, respectively, versus the prior-year, not including the benefit of the DuPont prepayment originally received in February 2016.
Outlook
"We are gaining momentum this year from the success of our transformation plan, including cost reductions, portfolio optimization, the ramp up of Opteon™ products and the expansion at Altamira," Vergnano continued. "We expect these initiatives along with our TiO2 price increases will deliver full-year Adjusted EBITDA greater than 2015 and generate modestly positive free cash flow. At this point in the year, we believe that our full-year capital expenditures are tracking slightly below $400 million, primarily due to the shift in the timing of the cyanide expansion. We intend to increase our investment in our Corpus Christi site to add flexibility for our anticipated Opteon™ expansion. We are also investing in other high-return capital projects that will enhance opportunities in our core businesses. We have gained confidence in our ability to realize our transformation plan goals of delivering $350 million of cost reductions and $150 million in Adjusted EBITDA associated with Opteon™ and Altamira through 2017. We believe that we are increasingly well-positioned to continue to strengthen our balance sheet and enhance Chemours' market leadership as we move forward."
Conference Call
As previously announced, Chemours will hold a conference call and webcast on Tuesday, August 9, 2016 at 8:30 AM EDT. The webcast and additional presentation materials can be accessed by visiting the Events & Presentations page of the Chemours investor website, investors.chemours.com. A webcast replay of the conference call will be available on the Chemours investor website.
1 Excludes $131 million of benefit from DuPont prepayment.
— — — — — — — — — — —
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 8,000 employees across 35 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com.
http://www.prnewswire.com/news-releases/the-chemours-company-announces-second-quarter-results-reports-substantial-progress-on-transformation-plan-initiatives-300310818.html
Enterprising Investor
9 years ago
Chemours Signs Definitive Agreement to Sell Sulfur Products to Veolia (6/14/16)
Agreement Marks Completion of Chemical Solutions Portfolio Review--Part of Chemours Transformation Plan
WILMINGTON, Del., June 14, 2016 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, has signed a definitive agreement to sell the assets which comprise its Sulfur Products business, part of its Chemical Solutions segment, to Veolia North America for $325 million in cash. The company anticipates closing the transaction within the second half of 2016, subject to customary closing conditions and regulatory approvals.
"Today marks the completion of our Chemical Solutions portfolio review—a key milestone in our five-point transformation plan," said Mark Vergnano, Chemours president and CEO. "In less than one year, we sold our aniline facility in Beaumont, Texas; began cost improvement efforts in our Methylamines business in Belle, W.Va.; began shutdown of our Reactive Metals Business in Niagara Falls, N.Y.; and announced the sale of our Clean and Disinfect and Sulfur businesses. Once complete, we will have a lower capital-intensive and streamlined Chemical Solutions portfolio that includes our growing Cyanides business. The total gross proceeds from the three divestitures will be approximately $700 million, providing strategic flexibility as Chemours completes its transformation plan."
Sulfur Products, with approximately $250 million in revenue, is a leading provider of sulfuric acid products and services to a range of industries in North America. It is a leading provider of spent acid regeneration (SAR) and sulfur gas recovery (SGR) services, non-fuming sulfuric acid and higher value sulfur derivatives (HVSDs). There are approximately 240 employees supporting Sulfur Products primarily located at 7 production sites in North America.
Barclays is acting as financial advisor and Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Chemours.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 8,000 employees across 35 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com.
http://www.prnewswire.com/news-releases/chemours-signs-definitive-agreement-to-sell-sulfur-products-to-veolia-300284173.html
Enterprising Investor
9 years ago
Chemours Strongly Refutes Citron Report (6/02/16)
WILMINGTON, Del., June 2, 2016 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) strongly refutes the report by Citron Research issued today.
Chemours, a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, was created to build on its fundamental strengths.
Upon becoming an independent company less than one year ago, Chemours immediately launched a five-point transformation plan to improve Adjusted EBITDA by $500 million over 2015 levels and reduce its leverage ratio to approximately three times in 2017. Chemours continues to execute on all aspects of its plan by reducing cost, optimizing its portfolio, growing market positions, refocusing investments and enhancing its organization. The company has taken swift and decisive action under this plan and has already delivered significant cost reductions while strengthening its liquidity position. Chemours is making major investments in key growth initiatives, and continues to progress the strategic review of its Chemical Solutions business.
The company reaffirms its 2016 outlook of Adjusted EBITDA above the 2015 performance, generating modestly positive free cash flow. This includes the expectation of $200 million of cost savings realized in 2016.
Information about Chemours businesses, market positions and financial performance is available on Chemours.com.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 8,100 employees across 35 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com or follow Chemours on Twitter at @chemours.
http://www.prnewswire.com/news-releases/chemours-strongly-refutes-citron-report-300279108.html
stocktrademan
10 years ago
$CC recent news/filings
bearish 6.01
## source: finance.yahoo.com
Thu, 19 Nov 2015 14:07:38 GMT ~ CHEMOURS CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151119/cc8-k.html
*********************************************************
Thu, 19 Nov 2015 13:02:00 GMT ~ 8:02 am Chemours to sell its aniline facility in Beaumont, Texas to Dow Chemical (DOW) for ~$140 mln in cash
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#cc
*********************************************************
Thu, 19 Nov 2015 13:00:00 GMT ~ Chemours Signs Definitive Agreement to Sell Aniline Facility
[PR Newswire] - WILMINGTON, Del., Nov. 19, 2015 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts ...
read full: http://finance.yahoo.com/news/chemours-signs-definitive-agreement-sell-130000058.html
*********************************************************
Tue, 17 Nov 2015 20:52:00 GMT ~ Low P/E Stocks Ready for a Turnaround?
read full: http://www.investopedia.com/stock-analysis/cotd/111715/low-pe-stocks-ready-turnaround-cc-nsr-sdlp.aspx?partner=YahooSA
*********************************************************
Tue, 17 Nov 2015 18:34:00 GMT ~ Chemours Breaks Ground for World's First Full-Scale Production of HFO-1336mzz
[PR Newswire] - WILMINGTON, Del., Nov. 17, 2015 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts ...
read full: http://finance.yahoo.com/news/chemours-breaks-ground-worlds-first-183400538.html
*********************************************************
$CC charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CC company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CC/company-info
Ticker: $CC
OTC Market Place: Not Available
CIK code: not found
Company name: Chemours Company (The)
Incorporated In:
$CC share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$CC extra dd links
Company name: Chemours Company (The)
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CC/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CC/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CC+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CC+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CC+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CC/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CC/news - http://finance.yahoo.com/q/h?s=CC+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CC/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CC/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CC/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CC/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CC/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CC/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CC/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CC/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CC+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CC
DTCC (dtcc.com): http://search2.dtcc.com/?q=Chemours+Company+%28The%29&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Chemours+Company+%28The%29
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Chemours+Company+%28The%29&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CC/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CC
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CC/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CC/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CC/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CC/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CC/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CC/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CC/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CC&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CC
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CC/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CC+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CC+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CC
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CC
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CC+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CC/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CC+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CC.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CC
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CC/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CC/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CC/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CC/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CC
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CC
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CC:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CC
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CC
$CC DD Notes ~ http://www.ddnotesmaker.com/CC
Enterprising Investor
10 years ago
Chemours Announces Fourth Quarter Dividend (9/01/15)
WILMINGTON, Del., Sept. 1, 2015 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that its Board of Directors declared a quarterly cash dividend of $0.03 per share on the company's common stock for the fourth quarter of 2015. The dividend will be paid on December 14, 2015 to stockholders of record as of the close of business on November 13, 2015. This is the first dividend declared by Chemours as an independent publicly traded company.
"Today's announcement is in-line with our five-point transformation plan to deliver enhanced Adjusted EBITDA and improved free cash flow, while strengthening our balance sheet and rewarding our shareholders. Our focus remains on reducing costs, growing our market positions, optimizing our portfolio, refocusing our investments, and enhancing our company. Our actions are designed to reduce our net debt position, improve our financial flexibility, and, over time, allow us to be in a position to return additional cash to shareholders," said Mark Vergnano, president and CEO.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more, information please visit chemours.com.
http://www.prnewswire.com/news-releases/chemours-announces-fourth-quarter-dividend-300136342.html
Enterprising Investor
10 years ago
Chemours Commercializes New Opteon™ Refrigerants with Low Global Warming Potential in U.S. (8/25/15)
Opteon™ XP40 and Opteon™ XP10 Will Replace Refrigerants Deemed by the U.S. EPA as No Longer Acceptable in Commercial Refrigeration and Air Conditioning
WILMINGTON, Del., Aug. 25, 2015 /PRNewswire/ -- Chemours announced today that two new Opteon™ refrigerants with low global warming potential (GWP) are now commercially available in the United States. These are the first in a portfolio of low GWP stationary refrigerants that Chemours will introduce to the U.S. in the next few years.
The U.S. Environmental Protection Agency recently approval these new products, Opteon™ XP40 (R-449A) and Opteon™XP10 (R-513A), under the Significant New Alternatives Policy (SNAP) Program for use in commercial refrigeration and air conditioning applications.
The SNAP Program supports the transition away from ozone-depleting compounds by identifying permitted substitutes that offer lower overall risks to human health and the environment. The commercialization of Opteon™ XP40 and Opteon™XP10 will help the industry transition away from products that EPA has removed from the SNAP list in applications such as commercial refrigeration and air conditioning.
As recently announced, Chemours has significantly increased capacity for Opteon™ YF (HFO-1234yf). As the world's HFO-1234yf capacity leader, Chemours is uniquely positioned to support its customers' growing need for low-GWP products in commercial refrigeration, mobile air conditioning and other applications.
"There is a significant shift within the HVACR industry toward offerings with low global warming potential," said Thierry F.J. Vanlancker, president, Chemours Fluoroproducts. "Opteon™ low GWP products from Chemours provide critical solutions in response to the regulatory and sustainability demands throughout the world. These solutions not only enable our customers to meet these stringent demands, but they also improve energy efficiency and thereby further reduce the overall climate impact."
Contractors, supermarkets and other equipment owners can rely on the Opteon™ family of refrigerants to ease the transition away from high GWP refrigerants such as R-404A, 507 and 134a. Opteon™ XP40 delivers a 67 percent lower GWP and an 8-12 percent gain in energy efficiency compared to R-404A. Opteon™ XP10 offers a 56 percent lower GWP than R-134a. Both products have been approved by major original equipment manufacturers.
As the leading industry supplier of more environmentally sustainable refrigerants, foams and aerosol propellants, Chemours has invested hundreds of millions of dollars to bring to the market new Opteon™ products with no ozone depletion and low global warming potential. The company and its suppliers have plans to invest hundreds of millions more in the next five years to bring online additional capacity of these more sustainable, high-performance products that serve a wide range of applications.
For more information, visit us at opteon.com.
About The Chemours Company
The Chemours Company helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise, and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™ Viton™, Opteon™ and Nafion™. Chemours has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information, please visit chemours.com or follow Chemours on Twitter at @chemours.
http://www.prnewswire.com/news-releases/chemours-commercializes-new-opteon-refrigerants-with-low-global-warming-potential-in-us-300132619.html
Enterprising Investor
10 years ago
Chemours Consolidates and Strengthens TiO2 Business as Part of Five-Point Transformation Plan (8/20/15)
WILMINGTON, Del., Aug. 20, 2015 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today two decisions that are elements of the company's five-point transformation plan.
The company will close its Edge Moor manufacturing site located outside Wilmington, Delaware, which produces titanium dioxide (TiO2) and will shut down a TiO2 line (line 3) at its Johnsonville plant in New Johnsonville, Tennessee. Together, these actions will eliminate roughly 150,000 metric tonnes of TiO2 capacity while refocusing TiO2 production at four manufacturing sites that employ the full range of Chemours TiO2 technology strengths. These changes position Chemours to grow in the TiO2 industry by enhancing its production capabilities. Most importantly, they allow the company to continue to meet the needs of its customers around the globe.
"The decisions we are announcing today are connected directly to our five-point transformation plan, which sets out a clear, achievable path to our becoming a higher value chemistry company," said Mark Vergnano, president and CEO of Chemours.
The Edge Moor plant is configured to produce a TiO2 product for use in the paper industry, in applications that have declined steadily for years, with an accompanying slowdown in demand that has resulted in underused capacity at Edge Moor. Chemours will work with current Edge Moor TiO2 customers to continue to provide them with similar product from the company's Johnsonville plant.
The Edge Moor plant has approximately 200 employees and 130 contractors. Chemours will redeploy employees wherever possible and where redeployment is not possible employees will receive severance benefits.
"A plant closure is never an easy decision, because of its impact on people who are valued members of our company," said E. Bryan Snell, president of Chemours Titanium Technologies. "However, we believe this is the right business decision. Chemours is committed to the TiO2 market, and these changes position us for growth in the industry."
"Our manufacturing capabilities are our greatest strength," added Snell. "Our plants in Mississippi, Tennessee, Mexico and Taiwan enjoy industry-leading productivity, as well as the ability to use ore feedstock across the quality spectrum. These factors give us a low-cost position that is a key competitive advantage. Meanwhile, underused capacity at our Edge Moor plant keeps it from being cost-effective. And, the line at Johnsonville (line 3) is relatively small scale and high cost compared to our other production units. By shutting these down we're concentrating our resources in a way that plays to our strengths."
As part of the company's transformation plan, these closures are expected to result in a $45 million annual net cost reduction. The company will incur non-cash charges of approximately $110 million related to the facility closing in the third quarter. Additional restructuring and other charges related to severance, decommissioning and site redevelopment are expected to be in the range of $75 million to $85 million and incurred during the next two-to-three years.
The company is targeting the end of September to stop production at Edge Moor and Johnsonville line 3. At Edge Moor, Chemours expects to complete decommissioning around March 2016 and then begin dismantling facilities, which could take a year or longer depending on future use of the site. Chemours will work with all of our site customers during this transition.
To help ease this transition for the community, Chemours will begin immediately exploring options for site redevelopment that align with the best interests of the surrounding Edge Moor community and local and state economic development leaders.
The Chemours five-point transformation plan is focused on five strategic elements: reducing structural costs, growing market positions, refocusing investments, optimizing the portfolio, and enhancing the organization.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more, information please visit chemours.com.
http://www.prnewswire.com/news-releases/chemours-consolidates-and-strengthens-tio2-business-as-part-of-five-point-transformation-plan-300130637.html
Enterprising Investor
10 years ago
The Chemours Company Comments on DuPont Performance Chemicals Second Quarter 2015 Segment Results (7/28/15)
WILMINGTON, Del., July 28, 2015 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global leader in titanium technologies, fluoroproducts and chemical solutions, today commented that continued challenging market conditions are reflected in the second quarter 2015 financial results for the Performance Chemicals segment of E. I. du Pont de Nemours and Company (DuPont). During the period, Chemours, which separated from DuPont on July 1, 2015, was a wholly-owned subsidiary of DuPont comprised of the businesses within the Performance Chemicals segment.
Today, DuPont reported Performance Chemicals segment net sales in the second quarter of $1.5 billion and segment operating earnings of $113 million. Chemours stated that second quarter performance reflected a sequential improvement in titanium dioxide shipments over the first quarter despite a slow start to the North American coatings season. This volume improvement was offset by continued weakness in the TiO2 pricing environment and currency headwinds across the businesses. Chemours expects to report second quarter 2015 financial results on a stand-alone basis on August 6th and will conduct a webcast conference call to review business performance.
Mark Vergnano, president and chief executive officer of Chemours, said: "Our focus is to improve our earnings and cash flow by aggressively reducing our structural costs and optimizing our portfolio. We expect that our previously announced restructuring actions taken in the second quarter will reduce costs by $40 million in the second half of 2015 and $80 million annually thereafter. We are also targeting further cost reductions to deliver an additional $120 million in savings. Combined, we expect that these actions will reduce spending levels by approximately $200 million by year-end 2016."
As previously disclosed, Chemours anticipates additional cash flow improvements from the management of its asset portfolio. The Altamira expansion, which is expected to be completed in mid-2016, is anticipated to provide annual Adjusted EBITDA benefits of $20 million to $70 million. Once Altamira is complete, capital expenditures will decline from the peak of capital spending in 2014. The ramp up of the Opteon™ refrigerant product line will drive increased revenue and Adjusted EBITDA in the Fluoroproducts segment in each of the next three years. Chemours also continues to evaluate alternatives to improve the profitability of the Chemicals Solution segment.
Vergnano continued, "We will share a more detailed review of our second quarter financial results on our call on August 6th. Additionally, we will clarify the opportunities and actions that we are taking to further transform Chemours."
Conference Call
Financial results on a stand-alone basis for the second quarter 2015 will be discussed during a conference call with management on August 6, 2015 at 8:00 AM EDT. Investors can access the call via webcast and view the accompanying slides by visiting the Events & Presentations page of Chemours' investor relations website, investors.chemours.com or by calling +1 (888) 424-8151 US Toll Free or +1 (847) 585-4422 US Toll, Passcode 67 42 438. A replay of the conference call will be available for 90 days.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™ Viton™, Opteon™ and Nafion™. Chemours has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more, information please visit chemours.com.
http://www.prnewswire.com/news-releases/the-chemours-company-comments-on-dupont-performance-chemicals-second-quarter-2015-segment-results-300119459.html
Enterprising Investor
10 years ago
The Chemours Company Completes Spin-Off from DuPont and Launches as an Independent, Publicly Traded Company (7/01/15)
WILMINGTON, Del., July 1, 2015 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today the completion of its spin-off from DuPont and its launch as an independent, publicly traded corporation. The company's common stock will begin trading "regular way" today on the New York Stock Exchange (NYSE) under the symbol "CC".
"We think of Chemours as a 200-hundred-year-old start-up," said Mark Vergnano, president and chief executive officer of Chemours. "We bring to the market a rich heritage based on our DuPont legacy and built on industry leadership and innovation adding the energy and agility of a customer-centered, global business fresh out of the starting gate. Our businesses are already known for pioneering application development and world-class product stewardship and safety. Our workforce is among the best in the industry; they bring years of experience, deep chemistry expertise, and outstanding engineering knowledge to our more than 5,000 customers across the globe.
"Together, we're going to build on our strengths, while becoming more streamlined and responsive," Vergnano continued. "We are focusing our efforts on reducing our cost structure, enhancing our portfolio, and driving growth that supports customer demand. Three strategic cornerstones define Chemours today: optimizing our asset base, increasing cash flow, and allocating capital strategically," he concluded.
Vergnano is joined by an experienced executive team, who bring extensive industry knowledge and strong operating skills to Chemours. They are:
•Mark E. Newman, Senior Vice President, Chief Financial Officer
•E. Bryan Snell, President, Titanium Technologies
•Thierry Vanlancker, President, Fluoroproducts
•Chris Siemer, President, Chemical Solutions
•Beth Albright, Senior Vice President, Human Resources
•Erich Parker, Vice President of Corporate Communications and Chief Brand Officer
•Dave Shelton, General Council & Corporate Secretary
About The Chemours Company
The Chemours Company helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise, and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon®, Ti-Pure®, Krytox® Viton®, Opteon® and Nafion®. Chemours has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information, please visit chemours.com or follow Chemours on Twitter at @chemours.
http://www.prnewswire.com/news-releases/the-chemours-company-completes-spin-off-from-dupont-and-launches-as-an-independent-publicly-traded-company-300107328.html
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
PStockPickz
4 years ago
MWM
6 years ago
whytestocks
6 years ago
Pisd
6 years ago
Level2Me
6 years ago
swanlinbar
6 years ago
ValueInvestor15
8 years ago
conix
9 years ago
DewDiligence
10 years ago
Hot Features
Premium
